MOH — Molina Healthcare, Inc.

Molina Healthcare Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Earnings Per Share (EPS): $2.35
• Premium Revenue: $10.2 billion
• Consolidated Medical Care Ratio (MCR): 91.1%
  • Medicaid MCR: 92%
  • Medicare MCR: 89.8%
  • Marketplace MCR: 84% (adjusted to ~79.5% after prior year risk adjustments)
• Adjusted Pretax Margin: 1.6%
• Operating Cash Flow: $1.1 billion
• Debt-to-Capital Ratio: Approximately 48%
• Days in Claims Payable: 44 days

2. Strategic Updates and Business Highlights

• Molina reaffirmed its full-year 2026 guidance of approximately $42 billion in premium revenue and adjusted EPS of at least $5.
• The company is focusing on enhancing medical cost management protocols to address high-cost trends observed in 2025.
• Transition of Medicare-Medicaid Plan (MMP) members to new integrated products was successfully completed.
• The company is strategically exiting the MAPD product for 2027, focusing on its Duals business in Medicare.
• Membership in the Marketplace segment increased slightly to 305,000, with a focus on renewal members to ensure stability.

3. Forward Guidance and Outlook

• Full-year 2026 premium revenue is expected to remain at approximately $42 billion.
• Medicaid membership attrition is now projected at 6%, up from a previous estimate of 2%, but revenue loss is expected to be offset by gains in the Marketplace segment.
• Medical cost trend for 2026 is assumed to be 5%, with confidence that the acuity shift trend seen in 2025 will not recur.
• The company plans to provide a detailed financial outlook through 2029 at the upcoming Investor Day on May 8.

4. Bad News, Challenges, or Points of Concern

• Increased Medicaid membership attrition, particularly in California, Illinois, New York, and Texas, raises concerns about future revenue.
• The company is cautious in its guidance due to the potential volatility in the Medicaid landscape and the impact of regulatory changes.
• The exit from the MAPD product could create uncertainty in the Medicare segment, although the transition to Duals products is expected to be beneficial.
• The overall medical cost environment remains challenging, with high-cost drugs and behavioral health costs still posing risks.

5. Notable Q&A Insights

• Management confirmed that the decline in low and no utilizers is at its lowest level, indicating reduced acuity shift risks.
• States are actively evaluating work requirements and redeterminations, which could impact membership levels gradually through 2027 and 2028.
• The company is exploring options to monetize the MAPD business while preparing to exit the market if necessary.
• There was a consensus that the first quarter's results were clean, with no unusual items affecting performance, but management prefers to wait for more data before adjusting guidance.
• The company expressed confidence in its ability to manage the new Florida Kids contract, which is expected to generate significant revenue.

Overall, Molina Healthcare reported solid first-quarter results but faces challenges with Medicaid membership attrition and the evolving regulatory landscape. The company remains optimistic about its strategic focus areas and long-term growth potential.